TREA

90592998 - NAXIO

Follow

Information

  • Trademark
  • 90592998
  • Serial Number
    90592998
  • Filing Date
    March 22, 2021
    3 years ago
  • Transaction Date
    February 16, 2024
    10 months ago
  • Status Date
    February 27, 2023
    a year ago
  • Published for Opposition Date
    November 30, 2021
    3 years ago
  • Location Date
    January 25, 2022
    2 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    JAGANNATHAN, SIDDHARTH
  • Attorney Name
    Shane Rumbaugh
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NAXIO
Case File Statements
  • GS0051: Pharmaceutical products for the treatment of cancer or infectious diseases, namely, genetically engineered hematopoietic cells for the treatment of cancer or infectious diseases; pharmaceutical preparations for cell therapy, namely, genetically engineered hematopoietic cells for the treatment of cancer or infectious diseases; biological preparations for cancer therapies and anti-infective therapies, namely, chimeric antigen receptors (CAR) and therapeutic preparations thereof, namely, viral vectors and plasmid vectors expressing CAR genes; therapeutic antibodies for use as immunotherapeutic agents for the treatment of cancer and infectious diseases; therapeutic T-cell receptors for use as immunotherapeutic agents for the treatment of cancer and infectious diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors and plasmid vectors
  • GS0441: Medical services, namely, in the extraction of human hematopoietic cells from patients and in genetically modifying hematopoietic cells for therapeutic purposes; Providing medical and therapy advice and consultancy in the field of medical therapies, namely, in the field of genetically engineered hematopoietic cells, cellular therapies, antibody therapies, and T-cell receptor therapies for the treatment of cancer or infectious diseases; providing information regarding the treatment of cancer and infectious diseases by means of a website, namely, in the treatment of cancer and infectious diseases by genetically engineered hematopoietic cells, cellular therapies, antibody therapies, and T-cell receptor therapies
  • GS0421: Industrial scientific analysis in the field of pharmaceuticals and biotechnology, namely, in the field of genetically engineered hematopoietic cells, cell therapies, chimeric antigen receptors (CAR), therapeutic antibodies, therapeutic T-cell receptors, viral vectors and plasmid vectors; scientific research services in the field of pharmaceuticals and biotechnology, namely, genetically modifying human or animal cells to enable cells to be used for therapeutic purposes; scientific research in the development of cancer therapies or anti-infective therapies, namely, in the development of genetically engineered hematopoietic cells, cell therapies, chimeric antigen receptors (CAR), therapeutic antibodies, therapeutic T-cell receptors and viral vectors and plasmid vectors
Case File Event Statements
  • 2/16/2024 - 10 months ago
    21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/16/2024 - 10 months ago
    20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/16/2024 - 10 months ago
    19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/27/2023 - a year ago
    18 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 2/27/2023 - a year ago
    17 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 6/24/2022 - 2 years ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/22/2022 - 2 years ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 6/22/2022 - 2 years ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 6/22/2022 - 2 years ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/19/2022 - 2 years ago
    12 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/25/2022 - 2 years ago
    11 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/6/2021 - 3 years ago
    10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/6/2021 - 3 years ago
    9 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/6/2021 - 3 years ago
    8 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/30/2021 - 3 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/30/2021 - 3 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/10/2021 - 3 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/26/2021 - 3 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/26/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/24/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/25/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP